Ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Can concepts from CLL be applied to other liquid and solid tumors?
Challenges associated with long-term therapies in CLL
Identification of high-risk disease using molecular profiling by Mymap